• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Firearms Training Systems

Firearms Training Systems

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Meggitt Training Systems Demonstrates Next Generation Simulation Training at Land Forces 2014

    Meggitt Training Systems Demonstrates Next Generation Simulation Training at Land Forces 2014

  2. Wake up with Back to School Healthy Breakfast Ideas from Stop & Shop

    Wake up with Back to School Healthy Breakfast Ideas from Stop & Shop

  3. Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

    Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

  4. Research and Markets: Fats and Oils Market by Type, Application & Geography - Global Trends & Forecast to 2019

    Research and Markets: Fats and Oils Market by Type, Application & Geography - Global Trends & Forecast to 2019

  5. Burger King Drops Lower Calorie Fries

    Burger King Drops Lower Calorie Fries

  6. Solazyme to Present at Two Upcoming Investor Conferences

    Solazyme to Present at Two Upcoming Investor Conferences

  7. Darling Ingredients Inc. Announces Second Quarter 2014 Earnings Conference Call And Webcast

    Darling Ingredients Inc. Announces Second Quarter 2014 Earnings Conference Call And Webcast

  8. Darling Ingredients Inc. Reports On Diamond Green Diesel Incident

    Darling Ingredients Inc. Reports On Diamond Green Diesel Incident

  9. FDA approves Jardiance® (empagliflozin) tablets for adults with type 2 diabetes

    FDA approves JardianceĀ® (empagliflozin) tablets for adults with type 2 diabetes

  10. Renewable Energy Group to Present at Upcoming Investor Conferences

    Renewable Energy Group to Present at Upcoming Investor Conferences

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.